Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.

ABSTRACT:

Importance

Emergency department (ED)-initiated buprenorphine for the treatment of opioid use disorder (OUD) is underused.

Objective

To evaluate whether provision of ED-initiated buprenorphine with referral for OUD increased after implementation facilitation (IF), an educational and implementation strategy.

Design, setting, and participants

This multisite hybrid type 3 effectiveness-implementation nonrandomized trial compared grand rounds with IF, with pre-post 12-month baseline and IF evaluation periods, at 4 academic EDs. The study was conducted from April 1, 2017, to November 30, 2020. Participants were ED and community clinicians treating patients with OUD and observational cohorts of ED patients with untreated OUD. Data were analyzed from July 16, 2021, to July 14

SUBMITTER: D'Onofrio G 

PROVIDER: S-EPMC10077107 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature